Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Itraconazole in Basal Cell Carcinoma
NCT03972748Phase 2Unknown
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Jan 2018
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of itraconazole in basal cell carcinoma (BCC), sponsored by Hospital de Clínicas de Porto Alegre. Status: unknown.
02
Drugs
itraconazole
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT03972748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03972748.